The Advantages of BioResponse DIM®

For centuries, people have known that cruciferous vegetables - broccoli, brussels sprouts, cabbage, and cauliflower - have value as medicinal plants. But only recently has modern science pinpointed the specific activity of individual cruciferous phytonutrients, especially diindolylmethane (DIM). To be beneficial, pure DIM needs to be made bioavailable. This hurdle was cleared in 1998 when BioResponse Nutrients developed its unique and patented nutrient delivery system - the only patented microencapsulated technology that guarantees the absorption of DIM.

Patented Formulation, Proven Absorption

Patented BioResponse DIM^® is the only microencapsulated formulation of pure DIM. BioResponse DIM^® is also the only DIM with proven absorption and benefits demonstrated in independently performed clinical studies. This patented technology is currently the only nutrient delivery method that assures predictable absorption and sustained delivery of diindolylmethane. Learn more about Absorption...

Originators of Microencapsulated, Bioavailable DIM

Michael A. Zeligs, M.D. is the Founder and CEO of BioResponse Nutrients and the co-inventor of patented, microencapsulated diindolylmethane (BioResponse-DIM^®). Dr. Zeligs was the first to discover novel nutritional approaches using cruciferous DIM, and has numerous patents for uses of DIM for hormonal health, breast health, menstrual health and weight management in women and men. As a physician dedicated to aging intervention, Dr. Zeligs has an extensive background that includes both clinical and academic work in the endocrinology of aging. Learn more about Our Company...

THE DIM Used in Clinical Trials

All clinical trials have only used the BioResponse DIM Formulation, including clinical trials using microencapsulated BioResponse DIM to study HPV, cervical dysplasia, uterine, and prostate health. Clinical trials are currently underway using BioResponse DIM in collaboration with Cornell University, the NYU School of Medicine, Cancer Research UK, Wayne State University, and New York Medical College. BioResponse Nutrients works with the National Cancer Institute (NCI) under a clinical trials agreement to discover the further health potential of DIM. Learn more about Clinical Trials...

LEARN MORE: About BioResponse DIM Ingredients...